Literature DB >> 12126604

Cardiac Transplantation: Pre-transplant Infectious Diseases Evaluation and Post-transplant Prophylaxis.

Susan Keay1.   

Abstract

Screening of recipients and donors of cardiac allografts for infectious pathogens, and the use of appropriate immunization and antimicrobial prophylaxis strategies, remain important for the control of infection following heart transplantation. However, the risk of infectious complications in a particular patient must often be weighed against the risk of delaying or denying allograft transplantation. In addition, the ongoing degree of immunosuppression and its contribution to the risk for infectious complications should also be considered to guide the length of prophylactic antimicrobial therapy and provide optimal patient care.

Entities:  

Year:  2002        PMID: 12126604     DOI: 10.1007/s11908-002-0019-x

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  80 in total

1.  Successful prevention of syphilis transmission from a multiple organ donor with serological evidence of syphilis.

Authors:  W J Ko; S H Chu; Y H Lee; P H Lee; C J Lee; S H Chao; S C Chang
Journal:  Transplant Proc       Date:  1998-11       Impact factor: 1.066

Review 2.  Prevention and treatment of cytomegalovirus infection and disease in heart transplant recipients.

Authors:  R K Avery
Journal:  Curr Opin Cardiol       Date:  1998-03       Impact factor: 2.161

3.  Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis.

Authors:  H Reichenspurner; P Gamberg; M Nitschke; H Valantine; S Hunt; P E Oyer; B A Reitz
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

4.  Management of left ventricular assist device infection with heart transplantation.

Authors:  T W Prendergast; B A Todd; A J Beyer; S Furukawa; H J Eisen; V P Addonizio; B J Browne; V Jeevanandam
Journal:  Ann Thorac Surg       Date:  1997-07       Impact factor: 4.330

5.  The use of contaminated donor organs in transplantation.

Authors:  G B Zibari; J Lipka; H Zizzi; K D Abreo; L Jacobbi; J C McDonald
Journal:  Clin Transplant       Date:  2000-08       Impact factor: 2.863

6.  Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis.

Authors:  M T Grattan; C E Moreno-Cabral; V A Starnes; P E Oyer; E B Stinson; N E Shumway
Journal:  JAMA       Date:  1989 Jun 23-30       Impact factor: 56.272

7.  Leishmaniasis in a heart transplant patient.

Authors:  A Golino; J M Duncan; B Zeluff; J DePriest; H A McAllister; B Radovancevic; O H Frazier
Journal:  J Heart Lung Transplant       Date:  1992 Jul-Aug       Impact factor: 10.247

8.  Toxoplasmosis in heart transplant recipients.

Authors:  A Gallino; M Maggiorini; W Kiowski; X Martin; W Wunderli; J Schneider; M Turina; F Follath
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-05       Impact factor: 3.267

9.  Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients.

Authors:  M R Keating; M A Guerrero; R C Daly; R C Walker; S F Davies
Journal:  Chest       Date:  1996-04       Impact factor: 9.410

10.  Outcome of Toxoplasma gondii mismatches in heart transplant recipients over a period of 8 years.

Authors:  K E Orr; F K Gould; G Short; J H Dark; C J Hilton; P A Corris; R Freeman
Journal:  J Infect       Date:  1994-11       Impact factor: 6.072

View more
  1 in total

1.  Management of the Patient After Heart Transplant.

Authors:  Michael A Mathier; Dennis M McNamara
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.